Literature DB >> 18387945

Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase.

Wei Bin Fang1, Dana M Brantley-Sieders, Yoonha Hwang, Amy-Joan L Ham, Jin Chen.   

Abstract

EphA2 is a member of the Eph family of receptor tyrosine kinases. EphA2 mediates cell-cell communication and plays critical roles in a number of physiological and pathologic responses. We have previously shown that EphA2 is a key regulator of tumor angiogenesis and that tyrosine phosphorylation regulates EphA2 signaling. To understand the role of EphA2 phosphorylation, we have mapped phosphorylated tyrosines within the intracellular region of EphA2 by a combination of mass spectrometry analysis and phosphopeptide mapping using two-dimensional chromatography in conjunction with site-directed mutagenesis. The function of these phosphorylated tyrosine residues was assessed by mutational analysis using EphA2-null endothelial cells reconstituted with EphA2 tyrosine-to-phenylalanine or tyrosine-to-glutamic acid substitution mutants. Phosphorylated Tyr(587) and Tyr(593) bind to Vav2 and Vav3 guanine nucleotide exchange factors, whereas Tyr(P)(734) binds to the p85 regulatory subunit of phosphatidylinositol 3-kinase. Mutations that uncouple EphA2 with Vav guanine nucleotide exchange factors or p85 are defective in Rac1 activation and cell migration. Finally, EphA2 mutations in the juxtamembrane region (Y587F, Y593F, Y587E/Y593E), kinase domain (Y734F), or SAM domain (Y929F) inhibited ephrin-A1-induced vascular assembly. In addition, EphA2-null endothelial cells reconstituted with these mutants were unable to incorporate into tumor vasculature, suggesting a critical role of these phosphorylation tyrosine residues in transducing EphA2 signaling in vascular endothelial cells during tumor angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18387945      PMCID: PMC2414276          DOI: 10.1074/jbc.M709934200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation.

Authors:  H Miao; E Burnett; M Kinch; E Simon; B Wang
Journal:  Nat Cell Biol       Date:  2000-02       Impact factor: 28.824

2.  P-Mod: an algorithm and software to map modifications to peptide sequences using tandem MS data.

Authors:  Beau T Hansen; Sean W Davey; Amy-Joan L Ham; Daniel C Liebler
Journal:  J Proteome Res       Date:  2005 Mar-Apr       Impact factor: 4.466

3.  EphB4 controls blood vascular morphogenesis during postnatal angiogenesis.

Authors:  Ralf Erber; Uta Eichelsbacher; Violetta Powajbo; Tobias Korn; Valentin Djonov; Jihong Lin; Hans-Peter Hammes; Rainer Grobholz; Axel Ullrich; Peter Vajkoczy
Journal:  EMBO J       Date:  2006-01-19       Impact factor: 11.598

4.  Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo.

Authors:  Dana M Brantley; Nikki Cheng; Erin J Thompson; Qing Lin; Rolf A Brekken; Philip E Thorpe; Rebecca S Muraoka; Douglas Pat Cerretti; Ambra Pozzi; Dowdy Jackson; Charles Lin; Jin Chen
Journal:  Oncogene       Date:  2002-10-10       Impact factor: 9.867

5.  Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice.

Authors:  Dana M Brantley-Sieders; Wei Bin Fang; Yoonha Hwang; Donna Hicks; Jin Chen
Journal:  Cancer Res       Date:  2006-11-01       Impact factor: 12.701

6.  Characterization of a novel Src-like adapter protein that associates with the Eck receptor tyrosine kinase.

Authors:  A Pandey; H Duan; V M Dixit
Journal:  J Biol Chem       Date:  1995-08-18       Impact factor: 5.157

7.  Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.

Authors:  Nicole K Noren; Mark Lu; Andrew L Freeman; Mitchell Koolpe; Elena B Pasquale
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-05       Impact factor: 11.205

8.  Overexpression of EPHA2 receptor destabilizes adherens junctions via a RhoA-dependent mechanism.

Authors:  Wei Bin Fang; Reneé C Ireton; Guanglei Zhuang; Takamune Takahashi; Al Reynolds; Jin Chen
Journal:  J Cell Sci       Date:  2008-01-15       Impact factor: 5.285

Review 9.  Eph receptor tyrosine kinases in tumor and tumor microenvironment.

Authors:  Dana Brantley-Sieders; Sonja Schmidt; Monica Parker; Jin Chen
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

10.  Ephrin-A5 induces rounding, blebbing and de-adhesion of EphA3-expressing 293T and melanoma cells by CrkII and Rho-mediated signalling.

Authors:  Isobel D Lawrenson; Sabine H Wimmer-Kleikamp; Peter Lock; Simone M Schoenwaelder; Michelle Down; Andrew W Boyd; Paul F Alewood; Martin Lackmann
Journal:  J Cell Sci       Date:  2002-03-01       Impact factor: 5.285

View more
  63 in total

1.  Hsp90 is an essential regulator of EphA2 receptor stability and signaling: implications for cancer cell migration and metastasis.

Authors:  Balasubramaniam Annamalai; Xueguang Liu; Udhayakumar Gopal; Jennifer S Isaacs
Journal:  Mol Cancer Res       Date:  2009-06-30       Impact factor: 5.852

2.  Transactivation of the receptor-tyrosine kinase ephrin receptor A2 is required for the low molecular weight hyaluronan-mediated angiogenesis that is implicated in tumor progression.

Authors:  Frances E Lennon; Tamara Mirzapoiazova; Nurbek Mambetsariev; Bolot Mambetsariev; Ravi Salgia; Patrick A Singleton
Journal:  J Biol Chem       Date:  2014-07-14       Impact factor: 5.157

3.  Specificity of HCPTP variants toward EphA2 tyrosines by quantitative selected reaction monitoring.

Authors:  Deepa Balasubramaniam; Lake N Paul; Kristoff T Homan; Mark C Hall; Cynthia V Stauffacher
Journal:  Protein Sci       Date:  2011-05-23       Impact factor: 6.725

4.  Receptor protein tyrosine phosphatase-receptor tyrosine kinase substrate screen identifies EphA2 as a target for LAR in cell migration.

Authors:  Hojin Lee; Anton M Bennett
Journal:  Mol Cell Biol       Date:  2013-01-28       Impact factor: 4.272

5.  EphA2 signaling following endocytosis: role of Tiam1.

Authors:  Pomme Boissier; Jin Chen; Uyen Huynh-Do
Journal:  Traffic       Date:  2013-10-10       Impact factor: 6.215

6.  Regulation of endothelial cell proliferation and vascular assembly through distinct mTORC2 signaling pathways.

Authors:  Shan Wang; Katherine R Amato; Wenqiang Song; Victoria Youngblood; Keunwook Lee; Mark Boothby; Dana M Brantley-Sieders; Jin Chen
Journal:  Mol Cell Biol       Date:  2015-01-12       Impact factor: 4.272

Review 7.  The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.

Authors:  Jill Wykosky; Waldemar Debinski
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

8.  Regulation of apoptosis in HL-1 cardiomyocytes by phosphorylation of the receptor tyrosine kinase EphA2 and protection by lithocholic acid.

Authors:  J Jehle; I Staudacher; F Wiedmann; Pa Schweizer; R Becker; Ha Katus; D Thomas
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

9.  EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer.

Authors:  Philip D Dunne; Sonali Dasgupta; Patrick G Johnston; Sandra Van Schaeybroeck; Jaine K Blayney; Darragh G McArt; Keara L Redmond; Jessica-Anne Weir; Conor A Bradley; Takehiko Sasazuki; Senji Shirasawa; Tingting Wang; Supriya Srivastava; Chee Wee Ong; Ken Arthur; Manuel Salto-Tellez; Richard H Wilson
Journal:  Clin Cancer Res       Date:  2015-08-17       Impact factor: 12.531

10.  Gene expression responses in male fathead minnows exposed to binary mixtures of an estrogen and antiestrogen.

Authors:  Natàlia Garcia-Reyero; Kevin J Kroll; Li Liu; Edward F Orlando; Karen H Watanabe; María S Sepúlveda; Daniel L Villeneuve; Edward J Perkins; Gerald T Ankley; Nancy D Denslow
Journal:  BMC Genomics       Date:  2009-07-13       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.